4//SEC Filing
Throsby Mark 4
Accession 0001209191-20-013286
CIK 0001651311other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 9:17 PM ET
Size
16.9 KB
Accession
0001209191-20-013286
Insider Transaction Report
Form 4
Merus N.V.MRUS
Throsby Mark
EVP & Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Shares
2020-02-24+87,621→ 100,903 total - Exercise/Conversion
Share Option (right to buy)
2020-02-24−47,816→ 1,017 totalExp: 2023-10-30→ Common Shares (47,816 underlying) - Exercise/Conversion
Share Option (right to buy)
2020-02-24−3,333→ 0 totalExp: 2020-09-04→ Common Shares (3,333 underlying) - Sale
Common Shares
2020-02-24$17.74/sh−57,088$1,012,741→ 43,815 total - Exercise/Conversion
Share Option (right to buy)
2020-02-24−5,000→ 0 totalExp: 2022-06-17→ Common Shares (5,000 underlying) - Exercise/Conversion
Share Option (right to buy)
2020-02-24−31,472→ 0 totalExp: 2023-03-16→ Common Shares (31,472 underlying)
Footnotes (10)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F10]Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on October 30, 2015.
- [F2]Exercise prices are denominated in Euros and ranged from 1.93 to 7.20, with a weighted average of 4.81.
- [F3]Amount represents the weighted average price of shares sold, which ranged from $17.07 to $18.56. Details of individual transactions are available upon request.
- [F4]Exercise price is denominated in Euros at 1.93.
- [F5]These options are fully vested.
- [F6]Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on September 4, 2012.
- [F7]Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on June 17, 2014.
- [F8]Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on March 16, 2015.
- [F9]Exercise price is denominated in Euros at 7.20.
Documents
Issuer
Merus N.V.
CIK 0001651311
Entity typeother
Related Parties
1- filerCIK 0001790357
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 9:17 PM ET
- Size
- 16.9 KB